1,328 research outputs found

    Efficiently analyzing large patient registries with Bayesian joint models for longitudinal and time-to-event data

    Get PDF
    The joint modeling of longitudinal and time-to-event outcomes has become a popular tool infollow-up studies. However, fitting Bayesian joint models to large datasets, such as patientregistries, can require extended computing times. To speed up sampling, we divided a patient registry dataset into subsamples, analyzed them in parallel, and combined the resultingMarkov chain Monte Carlo draws into a consensus distribution. We used a simulation studyto investigate how different consensus strategies perform with joint models. In particular,we compared grouping all draws together with using equal- and precision-weighted averages.We considered scenarios reflecting different sample sizes, numbers of data splits, and processor characteristics. Parallelization of the sampling process substantially decreased the timerequired to run the model. We found that the weighted-average consensus distributions forlarge sample sizes were nearly identical to the target posterior distribution. The proposedalgorithm has been made available in an R package for joint models, JMbayes2. This workwas motivated by the clinical interest in investigating the association between ppFEV1, acommonly measured marker of lung function, and the risk of lung transplant or death, using data from the US Cystic Fibrosis Foundation Patient Registry (35,153 individuals with372,366 years of cumulative follow-up). Splitting the registry into five subsamples resultedin an 85% decrease in computing time, from 9.22 to 1.39 hours. Splitting the data and finding a consensus distribution by precision-weighted averaging proved to be a computationallyefficient and robust approach to handling large datasets under the joint modeling framework

    Efficiently analyzing large patient registries with Bayesian joint models for longitudinal and time-to-event data

    Get PDF
    The joint modeling of longitudinal and time-to-event outcomes has become a popular tool infollow-up studies. However, fitting Bayesian joint models to large datasets, such as patientregistries, can require extended computing times. To speed up sampling, we divided a patient registry dataset into subsamples, analyzed them in parallel, and combined the resultingMarkov chain Monte Carlo draws into a consensus distribution. We used a simulation studyto investigate how different consensus strategies perform with joint models. In particular,we compared grouping all draws together with using equal- and precision-weighted averages.We considered scenarios reflecting different sample sizes, numbers of data splits, and processor characteristics. Parallelization of the sampling process substantially decreased the timerequired to run the model. We found that the weighted-average consensus distributions forlarge sample sizes were nearly identical to the target posterior distribution. The proposedalgorithm has been made available in an R package for joint models, JMbayes2. This workwas motivated by the clinical interest in investigating the association between ppFEV1, acommonly measured marker of lung function, and the risk of lung transplant or death, using data from the US Cystic Fibrosis Foundation Patient Registry (35,153 individuals with372,366 years of cumulative follow-up). Splitting the registry into five subsamples resultedin an 85% decrease in computing time, from 9.22 to 1.39 hours. Splitting the data and finding a consensus distribution by precision-weighted averaging proved to be a computationallyefficient and robust approach to handling large datasets under the joint modeling framework

    Review of quantitative and functional lung imaging evidence of vaping-related lung injury

    Get PDF
    IntroductionThe pulmonary effects of e-cigarette use (or vaping) became a healthcare concern in 2019, following the rapid increase of e-cigarette-related or vaping-associated lung injury (EVALI) in young people, which resulted in the critical care admission of thousands of teenagers and young adults. Pulmonary functional imaging is well-positioned to provide information about the acute and chronic effects of vaping. We generated a systematic review to retrieve relevant imaging studies that describe the acute and chronic imaging findings that underly vaping-related lung structure-function abnormalities.MethodsA systematic review was undertaken on June 13th, 2023 using PubMed to search for published manuscripts using the following criteria: [(“Vaping” OR “e-cigarette” OR “EVALI”) AND (“MRI” OR “CT” OR “Imaging”)]. We included only studies involving human participants, vaping/e-cigarette use, and MRI, CT and/or PET.ResultsThe search identified 445 manuscripts, of which 110 (668 unique participants) specifically mentioned MRI, PET or CT imaging in cases or retrospective case series of patients who vaped. This included 105 manuscripts specific to CT (626 participants), three manuscripts which mainly used MRI (23 participants), and two manuscripts which described PET findings (20 participants). Most studies were conducted in North America (n = 90), with the remaining studies conducted in Europe (n = 15), Asia (n = 4) and South America (n = 1). The vast majority of publications described case studies (n = 93) and a few described larger retrospective or prospective studies (n = 17). In e-cigarette users and patients with EVALI, key CT findings included ground-glass opacities, consolidations and subpleural sparing, MRI revealed abnormal ventilation, perfusion and ventilation/perfusion matching, while PET showed evidence of pulmonary inflammation.Discussion and conclusionPulmonary structural and functional imaging abnormalities were common in patients with EVALI and in e-cigarette users with or without respiratory symptoms, which suggests that functional MRI may be helpful in the investigation of the pulmonary health effects associated with e-cigarette use

    Relativistic Treatment of Hypernuclear Decay

    Get PDF
    We compute for the first time the decay width of lambda-hypernuclei in a relativistic mean-field approximation to the Walecka model. Due to the small mass difference between the lambda-hyperon and its decay products---a nucleon and a pion---the mesonic component of the decay is strongly Pauli blocked in the nuclear medium. Thus, the in-medium decay becomes dominated by the non-mesonic, or two-body, component of the decay. For this mode, the lambda-hyperon decays into a nucleon and a spacelike nuclear excitation. In this work we concentrate exclusively on the pion-like modes. By relying on the analytic structure of the nucleon and pion propagators, we express the non-mesonic component of the decay in terms of the spin-longitudinal response function. This response has been constrained from precise quasielastic (p,n) measurements done at LAMPF. We compute the spin-longitudinal response in a relativistic random-phase-approximation model that reproduces accurately the quasielastic data. By doing so, we obtain hypernuclear decay widths that are considerably smaller---by factors of two or three---relative to existing nonrelativistic calculations.Comment: Revtex: 18 pages and 4 postscript figure

    Effect of a High-Fat Diet and Metformin on Placental mTOR Signaling in Mice

    Get PDF
    Objective This study was aimed to measure the effects of a high-fat diet and metformin on placental mechanistic target of rapamycin (mTOR) signaling in mice. Study Design Pregnant friend virus B (FVB)-strain mice were allocated on embryonic day (e) 0.5 to one of four groups; group 1: control diet (CD, 10% fat) + control treatment (CT), group 2: CD + metformin treatment (MT), group 3: high-fat diet (HFD, 60% fat) + CT, and group 4: HFD + MT. Metformin (2.5 mg/mL) was provided in water; CT mice received water. Fetuses and placentas were collected. Western blot measured placental p-Akt and p-S6 expression. Results 20 dams (five/group) and 192 fetuses were studied. Compared with CD-fed, HFD-fed dams had higher placental p-Akt protein expression (p < 0.0001). Among HFD-dams, placental p-Akt was higher in metformin-treated compared with control-treated (p < 0.001). Among CD-fed dams, there was no significant difference in placental p-S6 expression in MT versus CT groups. Among HFD-fed dams placental p-S6 expression was lower in those exposed to metformin-treated versus controls (p = 0.001). Conclusion Increased placental mTOR signaling and metformin inhibition of placental mTOR signaling only occurred in the presence of an HFD exposure. These findings suggest that metformin may modulate placental mTOR signaling in the presence of metabolic exposures during pregnancy

    Personalization Paradox in Behavior Change Apps:Lessons from a Social Comparison-Based Personalized App for Physical Activity

    Get PDF
    Social comparison-based features are widely used in social computing apps. However, most existing apps are not grounded in social comparison theories and do not consider individual differences in social comparison preferences and reactions. This paper is among the first to automatically personalize social comparison targets. In the context of an m-health app for physical activity, we use artificial intelligence (AI) techniques of multi-armed bandits. Results from our user study (n=53) indicate that there is some evidence that motivation can be increased using the AI-based personalization of social comparison. The detected effects achieved small-to-moderate effect sizes, illustrating the real-world implications of the intervention for enhancing motivation and physical activity. In addition to design implications for social comparison features in social apps, this paper identified the personalization paradox, the conflict between user modeling and adaptation, as a key design challenge of personalized applications for behavior change. Additionally, we propose research directions to mitigate this Personalization Paradox

    Genomic analysis of the function of the transcription factor gata3 during development of the Mammalian inner ear

    Get PDF
    We have studied the function of the zinc finger transcription factor gata3 in auditory system development by analysing temporal profiles of gene expression during differentiation of conditionally immortal cell lines derived to model specific auditory cell types and developmental stages. We tested and applied a novel probabilistic method called the gamma Model for Oligonucleotide Signals to analyse hybridization signals from Affymetrix oligonucleotide arrays. Expression levels estimated by this method correlated closely (p<0.0001) across a 10-fold range with those measured by quantitative RT-PCR for a sample of 61 different genes. In an unbiased list of 26 genes whose temporal profiles clustered most closely with that of gata3 in all cell lines, 10 were linked to Insulin-like Growth Factor signalling, including the serine/threonine kinase Akt/PKB. Knock-down of gata3 in vitro was associated with a decrease in expression of genes linked to IGF-signalling, including IGF1, IGF2 and several IGF-binding proteins. It also led to a small decrease in protein levels of the serine-threonine kinase Akt2/PKB beta, a dramatic increase in Akt1/PKB alpha protein and relocation of Akt1/PKB alpha from the nucleus to the cytoplasm. The cyclin-dependent kinase inhibitor p27(kip1), a known target of PKB/Akt, simultaneously decreased. In heterozygous gata3 null mice the expression of gata3 correlated with high levels of activated Akt/PKB. This functional relationship could explain the diverse function of gata3 during development, the hearing loss associated with gata3 heterozygous null mice and the broader symptoms of human patients with Hearing-Deafness-Renal anomaly syndrome
    corecore